Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
Type:
Application
Filed:
May 14, 2019
Publication date:
August 29, 2019
Applicant:
EB IP LYBRIDOS B.V.
Inventors:
Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
Type:
Grant
Filed:
February 21, 2017
Date of Patent:
June 11, 2019
Assignee:
EB IP LYBRIDOS B.V.
Inventors:
Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
Type:
Application
Filed:
February 21, 2017
Publication date:
June 8, 2017
Applicant:
EB IP LYBRIDOS B.V.
Inventors:
Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
Type:
Grant
Filed:
December 4, 2015
Date of Patent:
March 21, 2017
Assignee:
EB IP LYBRIDOS B.V.
Inventors:
Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
Type:
Grant
Filed:
October 8, 2013
Date of Patent:
December 15, 2015
Assignee:
EB IP LYBRIDOS B.V.
Inventors:
Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange